Corona tablet also works against hair loss

The US Food and Drug Administration (FDA) has approved a pill for severe hair loss. Approval of the drug “baricitinib” will “help fill a significant unmet need for patients with severe alopecia areata,” said FDA Dermatology Director Kendall Marcus.

Drug previously approved against Corona

“Baricitinib” regulates inflammatory reactions and has so far been approved for the treatment of arthritis and corona patients in hospitals. Alopecia is an autoimmune disease that causes excessive hair loss. The disease was recently brought to the fore by the case of US actress Jada Pinkett Smith. Her husband Will Smith slapped comedian Chris Rock at the Oscars for a joke about his wife’s bald head. The disease is not uncommon: in the USA alone, more than 300,000 people are affected each year.

Clinical trials in people with alopecia

The drug’s approval is based on the results of two clinical trials involving a total of 1,200 adults with severe alopecia. In each study, participants were divided into three groups: one group that received only placebo, a second group that received a two-milligram daily dose, and a third group that received a four-milligram daily dose. After 36 weeks, almost 40 percent of the people who received the higher dose had regrown 80 percent of their scalp hair. For comparison: in the group with the lower dosage it was only 23 percent, in the control group only five percent.

The most common side effects of “baricitinib” included upper respiratory tract infections, headaches, acne, elevated cholesterol, and an increase in an enzyme called creatine phosphokinase.

There are other treatments for severe hair loss, but they are considered experimental and not approved in the United States. According to the FDA, “Baricitinib” is the first drug that works in alopecia throughout the body and not just locally.